Delivery Order SPE2DB22D2005-SPE2DB25FJRP7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.16 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 mL (5 mL vials) on July 30, 2025, with completion scheduled for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $1,179.45 and a firm fixed price structure. This delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,218.01 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL units. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, was awarded competitively with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $3,226.34 and a firm fixed price structure. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The ultimate completion date for this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL quantities, with a ceiling value of $4,992.01. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract utilizes no set-aside designation, indicating it was awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $2,289.37 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL vials, with an ultimate completion date of July 30, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,979.20, is for the delivery of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a $10,795.82 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, with an ultimate completion date of June 18, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Betamethasone SP-AC 30 mg/5 ml 5 ml medication. The contract has a firm fixed price of $1,174.93 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- On August 11, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml vials with a ceiling value of $27,745.17. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRP7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,165.13 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive DLA contract vehicle. The SPE2DX IDC enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This particular delivery order for the corticosteroid medication supports ongoing federal medical supply requirements within the existing contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/13/25 |